Grifols (GIFLF) Net Cash Flow Growth (5y) (2015 - 2024)
Powered by 
Analysis
Grifols (GIFLF) Net Cash Flow Growth (5y) (2015 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn |
| 10 | Grifols | 7.54 Bn | 9.09 Bn | 3.33 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -34.91% |
| Dec 31, 2023 | -18.36% |
| Dec 31, 2022 | -19.67% |
| Mar 31, 2020 | 22.36% |
| Dec 31, 2019 | -23.17% |
| Mar 31, 2019 | -16.63% |
| Dec 31, 2018 | 21.15% |
| Jun 30, 2018 | -34.32% |
| Mar 31, 2018 | 37.73% |
| Dec 31, 2017 | 73.21% |
| Jun 30, 2017 | 7.55% |
| Mar 31, 2017 | 54.65% |
| Dec 31, 2016 | -21.05% |
| Sep 30, 2016 | -16.53% |
| Dec 31, 2015 | -47.92% |
| Sep 30, 2015 | 38.79% |